alicaforsen   Click here for help

GtoPdb Ligand ID: 14703

Synonyms: ISIS 2302 | ISIS2302
Immunopharmacology Ligand
Compound class: Nucleic acid
Comment: Alicaforsen (ISIS 2302) is a phosphorothioate antisense oligonucleotide (ASO) that targets intercellular adhesion molecule-1 (ICAM-1) mRNA (hybridising to a sequence in the 3' UTR) to reduce ICAM-1 protein synthesis.

Full nucleotide sequence is: all-P-(R)-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thiocytidylyl- (3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl- (3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-P-thioadenylyl- (3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thiocytidylyl- (3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'- deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'- deoxy-P-thioadenylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P- thiocytidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-P- thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl- (3'→5')-2'-deoxyadenosine
No information available.
Summary of Clinical Use Click here for help
Alicaforsen (ISIS 2302) was progressed as a clinical candidate with potential to reduce inflammation in Crohn's disease and ulcerative colitis.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00048295 Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease Phase 3 Interventional Ionis Pharmaceuticals, Inc.
NCT00048113 Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease Phase 3 Interventional Ionis Pharmaceuticals, Inc.